Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513162-22-000051
Filing Date
2022-04-14
Accepted
2022-04-14 08:30:39
Documents
47
Period of Report
2022-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmra-20220228.htm   iXBRL 10-Q 1124312
2 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 8210
3 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 9053
4 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 4309
5 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 4392
  Complete submission text file 0001513162-22-000051.txt   4809329

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20220228.xsd EX-101.SCH 28534
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmra-20220228_cal.xml EX-101.CAL 34022
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20220228_def.xml EX-101.DEF 177441
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20220228_lab.xml EX-101.LAB 297151
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20220228_pre.xml EX-101.PRE 185987
41 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20220228_htm.xml XML 780627
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 22826079
SIC: 2835 In Vitro & In Vivo Diagnostic Substances